Erlotinib/osimertinibDevelopment of resistance in advanced lung adenocarcinoma: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2019年 / 1781卷 / 1期

关键词：

D O I：

10.1007/s40278-019-71983-9

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：160 / 160

相关论文

共 50 条

[1] Erlotinib/osimertinibDevelopment of resistance in lung adenocarcinoma: case report
[J]. Reactions Weekly, 2019, 1765 (1) : 158 - 158
[2] Erlotinib/osimertinibDevelopment of resistance in lung adenocarcinoma: case report
[J]. Reactions Weekly, 2019, 1749 (1) : 180 - 180
[3] OsimertinibDevelopment of drug resistance in advanced lung adenocarcinoma: case report
[J]. Reactions Weekly, 2020, 1804 (1) : 230 - 230
[4] Erlotinib/osimertinibDevelopment of drug resistance in lung adenocarcinoma: 2 case reports
[J]. Reactions Weekly, 2017, 1668 (1) : 174 - 174
[5] OsimertinibDevelopment of drug resistance in lung adenocarcinoma: case report
[J]. Reactions Weekly, 2020, 1809 (1) : 199 - 199
[6] Gefitinib/osimertinibDevelopment of resistance in lung adenocarcinoma: case report
[J]. Reactions Weekly, 2019, 1738 (1) : 129 - 129
[7] OsimertinibDevelopment of resistance in metastatic lung adenocarcinoma: case report
[J]. Reactions Weekly, 2021, 1841 (1) : 203 - 203
[8] Icotinib/osimertinibDevelopment of resistance in lung adenocarcinoma: case report
[J]. Reactions Weekly, 2021, 1855 (1) : 175 - 175
[9] Erlotinib/osimertinibDevelopment of drug resistance: case report
[J]. Reactions Weekly, 2019, 1742 (1) : 97 - 97
[10] Gefitinib/osimertinibDevelopment of drug resistance in lung adenocarcinoma: case report
[J]. Reactions Weekly, 2018, 1700 (1) : 127 - 127

← 1 2 3 4 5 →